Factors associated with electrocardiographic left ventricular hypertrophy among patients with hypertension in Thailand
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Left ventricular hypertrophy (LVH) strongly predicts cardiovascular diseases (CVD) and death. One-fourth of Thai adults suffer from hypertension. Nevertheless, the information on LVH among Thai patients with hypertension is not well characterized. We aimed to identify the prevalence and factors associated with electrocardiographic LVH (ECG-LVH) among patients with hypertension in Thailand.The present study obtained the dataset from the Thailand Diabetes Mellitus/Hypertension study, which included hypertension patients aged 20 years and older receiving continuous care at outpatient clinics in hospitals nationwide in 2011–2015 and 2018. Meanwhile, those without a record of 12-lead electrocardiography (ECG) were excluded from the analysis. ECG-LVH was defined as the LVH noted regarding ECG interpretation in the medical records. Multivariable logistic regression analysis was utilized for determining factors associated with ECG-LVH and presented as the adjusted odds ratio (AOR) and 95% confidence interval (CI). From 226,420 hypertensive patients in the Thailand Diabetes Mellitus/Hypertension study, 38,807 individuals (17.1%) with ECG data recorded were included in the analysis. The mean age was 64.8 ± 11.5 years, and 62.2% were women. Overall, 1,557 study participants had ECG-LVH, with an estimated prevalence of 4.0% (95% CI, 3.8–4.2%). Age-adjusted ECG-LVH prevalence among women and men was 3.4 and 5.1%, respectively ( P < 0.001). Multivariable analysis determined factors associated with ECG-LVH, including being men (AOR, 1.49; 95% CI, 1.31–1.69), individuals aged 70 to 79 years (AOR, 1.56; 95% CI, 1.20–2.02) and ≥ 80 years (AOR, 2.10; 95% CI, 1.58–2.78) compared to individuals aged less than 50 years, current smokers (AOR, 1.26; 95% CI, 1.09–1.46) compared to those who never smoked, systolic blood pressure ≥ 140 mmHg and diastolic blood pressure ≥ 90 mmHg (AOR, 1.58; 95% CI, 1.30–1.92) compared to systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 mmHg. The current study illustrated the prevalence of ECG-LVH among Thai patients with hypertension who had ECG recorded and identified high-risk groups who tended to have ECG-LVH. The findings underscore the need for targeted interventions, particularly among high-risk groups such as older individuals, men, and current smokers, to address modifiable factors associated with ECG-LVH.
Abstract
Onefourth of Thai adults suffer from hypertension. Nevertheless, the information on LVH among Thai patients with hypertension is not well characterized. We aimed to identify the prevalence and factors associated with electrocardiographic LVH (ECG-LVH) among patients with hypertension in Thailand. Methods The present study obtained the dataset from the Thailand Diabetes Mellitus/Hypertension study, which included hypertension patients aged 20 years and older receiving continuous care at outpatient clinics in hospitals nationwide in 2011–2015 and 2018. Meanwhile, those without a record of 12-lead electrocardiography (ECG) were excluded from the analysis. ECG-LVH was defined as the LVH noted regarding ECG interpretation in the medical records. Multivariable logistic regression analysis was utilized for determining factors associated with ECG-LVH and presented as the adjusted odds ratio (AOR) and 95% confidence interval (CI). Results From 226,420 hypertensive patients in the Thailand Diabetes Mellitus/Hypertension study, 38,807 individuals (17.1%) with ECG data recorded were included in the analysis. The mean age was 64.8 ± 11.5 years, and 62.2% were women. Overall, 1,557 study participants had ECG-LVH, with an estimated prevalence of 4.0% (95% CI, 3.8–4.2%). Age-adjusted ECG-LVH prevalence among women and men was 3.4 and 5.1%, respectively (P < 0.001). Multivariable analysis determined factors associated with ECG-LVH, including being men (AOR, 1.49; 95% CI, 1.31–1.69), individuals aged 70 to 79 years (AOR, 1.56; 95% CI, 1.20–2.02) and ≥ 80 years (AOR, 2.10; 95% CI, 1.58–2.78) compared to individuals aged less than 50 years, current smokers (AOR, 1.26; 95% CI, 1.09–1.46) compared to those who never smoked, systolic blood pressure ≥ 140 mmHg and diastolic blood pressure ≥ 90 mmHg (AOR, 1.58; 95% CI, 1.30–1.92) compared to systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 mmHg. Conclusions The current study illustrated the prevalence of ECG-LVH among Thai patients with hypertension who had ECG recorded and identified high-risk groups who tended to have ECG-LVH. The findings underscore the need for targeted interventions, particularly among high-risk groups such as older individuals, men, and current smokers, to address modifiable factors associated with ECG-LVH.
참고문헌 (44)
- Bornstein AB, "Left ventricular hypertrophy" (2023), StatPearls Publishing
- Shenasa M, "Hypertension, left ventricular hypertrophy, and sudden cardiac death", Int J Cardiol, 237, pp.60~63 (2017)
- Gosse P, "Left ventricular hypertrophy as a predictor of cardiovascular risk", J Hypertens Suppl, 23, pp.S27~S33 (2005)
- Porthan K, "ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death", Int J Cardiol, 276, pp.125~129 (2019)
- Tsao CW, "Left ventricular structure and risk of cardiovascular events : a Framingham heart study cardiac magnetic resonance study", J Am Heart Assoc, 4, pp.e002188~ (2015)
- Iribarren C, "Cohort study of ECG left ventricular hypertrophy trajectories : ethnic disparities, associations with cardiovascular outcomes, and clinical utility", J Am Heart Assoc, 6, pp.e004954~ (2017)
- Liao YY, "Risk factors for electrocardiographic left ventricular hypertrophy in a young Chinese general population : the Hanzhong adolescent cohort study", BMC Cardiovasc Disord, 21, pp.159~ (2021)
- Cuspidi C, "High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population", Hypertension, 73, pp.612~619 (2019)
- Viwatrangkul P, "Prevalence and associated factors of electrocardiographic left ventricular hypertrophy in a rural community, Central Thailand", Sci Rep, 11, pp.7083~ (2021)
- Ricciardi D, "Current diagnostic ECG criteria for left ventricular hypertrophy : is it time to change paradigm in the analysis of data?", J Cardiovasc Med(Hagerstown), 21, pp.128~133 (2020)
- Scheltens T, "The potential yield of ECG screening of hypertensive patients : the Utrecht health project", J Hypertens, 28, pp.1527~1533 (2010)
- Kunanon S, "2019 Thai guidelines on the treatment of hypertension : executive summary", J Med Assoc Thail, 104, pp.1729~1738 (2021)
- "Thai national health examination survey III (2003–2004)" (2004)[URL]
- "Thai national health examination survey IV (2008–2009)" (2009)[URL]
- "Thai national health examination survey V (2014)" (2014)[URL]
- "Thai national health examination survey VI (2019–2020)" (2019)[URL]
- Sakboonyarat B, "Characteristics and clinical outcomes of people with hypertension receiving continuous care in Thailand : a cross-sectional study", Lancet Reg Health Southeast Asia, 21, pp.100319~ (2023)
- Sriratanasathavorn C, "The prevalence of left ventricular hypertrophy and associated factors in a Thai population", J Med Assoc Thail, 83(Suppl 2), pp.S218~S222 (2000)
- "DAMUS: data archival for maximum utilization system" (2022)[URL]
- American Diabetes Association, "2. Classification and diagnosis of diabetes: standards of medical Care in Diabetes-2018", Diabetes Care, 41(Suppl 1), pp.S13~S27 (2018)
- Sokolow M, "The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads", Am Heart J, 37, pp.161~186 (1949)
- Okin PM, "Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products", J Am Coll Cardiol, 25, pp.417~423 (1995)
- Linden A, "Conducting sensitivity analysis for unmeasured confounding in observational studies using E-values : the evalue package", Stata J, 20, pp.162~175 (2020)
- Jobe M, "Electrocardiographic left ventricular hypertrophy among Gambian diabetes mellitus patients", Ghana Med J, 49, pp.19~24 (2015)
- Liao Y, "Left ventricular hypertrophy has a greater impact on survival in women than in men", Circulation, 92, pp.805~810 (1995)
- Verdecchia P, "Sudden cardiac death in hypertensive patients", Hypertension, 73, pp.1071~1078 (2019)
- Cheng S, "Correlates of echocardiographic indices of cardiac remodeling over the adult life course : longitudinal observations from the Framingham heart study", Circulation, 122, pp.570~578 (2010)
- Lindroos M, "Echocardiographic evidence of left ventricular hypertrophy in a general aged population", Am J Cardiol, 74, pp.385~390 (1994)
- Tracy E, "Cardiac tissue remodeling in healthy aging : the road to pathology", Am J Physiol Cell Physiol, 319, pp.C166~C182 (2020)
- Rodgers JL, "Cardiovascular risks associated with gender and aging", J Cardiovasc Dev Dis, 6, pp.19~ (2019)
- Sakboonyarat B, "Prevalence and associated factors of ischemic heart disease(IHD)among patients with diabetes mellitus : a nation-wide, cross-sectional survey", BMC Cardiovasc Disord, 18, pp.151~ (2018)
- Klingbeil AU, "A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension", Am J Med, 115, pp.41~46 (2003)
- Payne JR, "Left ventricular growth response to exercise and cigarette smoking : data from LARGE heart", Heart, 92, pp.1784~1788 (2006)
- Kolkenbeck-Ruh A, "Obesity, hypertension, and tobacco use associated with left ventricular remodeling and hypertrophy in south African women : birth to twenty plus cohort", BMC Cardiovasc Disord, 22, pp.403~ (2022)
- Leigh JA, "Smoking intensity and duration is associated with cardiac structure and function : the ECHOcardiographic study of Hispanics", Latinos, 2017, pp.4, e000614~
- Kaplan A, "Functional, cellular, and molecular remodeling of the heart under influence of oxidative cigarette tobacco smoke", Oxidative Med Cell Longev, 2017, pp.3759186~ (2017)
- Benowitz NL, "Cardiovascular toxicity of nicotine : implications for electronic cigarette use", Trends Cardiovasc Med, 26, pp.515~523 (2016)
- Deng Y, "Intensive blood pressure lowering improves left ventricular hypertrophy in older patients with hypertension : the STEP trial", Hypertension, 80, pp.1834~1842 (2023)
- Soliman EZ, "Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension : SPRINT(systolic blood pressure intervention trial)", Circulation, 136, pp.440~450 (2017)
- Mohan M, "Left ventricular hypertrophy in diabetic cardiomyopathy : a target for intervention", Front Cardiovasc Med, 8, pp.746382~ (2021)
- Somaratne JB, "Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community", Cardiovasc Diabetol, 10, pp.29~ (2011)
- Srivastava PM, "Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with type 2 diabetes", Clin Sci(Lond), 114, pp.313~320 (2008)
- Muddu M, "Prevalence, types and factors associated with echocardiographic abnormalities among newly diagnosed diabetic patients at Mulago hospital", Afr Health Sci, 16, pp.183~193 (2016)
- Levy D, "Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy", Circulation, 81, pp.815~820 (1990)